On August 4, JOINN rose 5.46% in regular trading, trading at HK$23.54/share, with turnover of HK$41.78 million.
On the news front, the Life Sciences Tools and Services sector rallied sharply across the board. WuXi AppTec surged 12.65%, GenScript Bio gained 8.1%, Pharmaron rose 7.49%, WuXi XDC climbed 5.94%, and WuXi Bio advanced 4.79%, with broad-based gains across the sector.
The rally was underpinned by multiple leading CRO companies reporting significant growth in new order signings during the first quarter, with industry order recovery momentum continuing. Additionally, JOINN had previously confirmed that the supply-demand balance for non-human primate experimental animals remains tight, with prices rising compared to prior periods. Separately, institutions have noted that CXO sector prosperity has entered an earnings delivery phase, with first-half performance pre-announcements from several peers showing substantial profit growth, providing fundamental support for the sector-wide rally.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments